United Orthopedic Corporation · TPEX:4129
United Orthopedic — 2025 Investor Conference
18 slides from United Orthopedic's conference presentation, Nov 27, 2025
Slide 1: United Orthopedic Corporation 2025 Investor Conference
United Orthopedic Corporation 2025 Investor Conference November 27, 2025
Slide 2: Safe Harbor Notice
Safe Harbor Notice Except for historical information set forth herein, this presentation contains certain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from what may be expressed or implied by such statements. Investors sh
Slide 3: Agenda
AGENDA I. 2025 first three quarters results II. Operations Status III. Q&A 3
Slide 4: 2025 Q3 Revenue
2025 Q3 Revenue NT$ 1,492 millions (YoY+32%) record high for a single quarter (NT$ millions) 2024 Q3 2025 Q3 YoY% Revenue 1,130.6 1,491.6 32% APAC 516.9 674.1 30% EMEA 326.6 485.4 49% AMERICA 287.1 332.0 16% 4
Slide 5: Revenue by Regions
Revenue by Regions 2024 Q3 2025 Q3 1,131M 1,492M AMERICA AMERICA 25% 22% APAC APAC 46% 45% EMEA EMEA 29% 33% 5
Slide 6: 2025 Q3 Performance (Quarterly Record High)
2025 Q3 Performance(Quarterly Record High) (NT$ thousands) 2024 Q3 2025 Q3 DIFF % Revenue 1,130,636 1,491,594 360,958 +32% Operating P/L 159,468 210,134 50,667 +32% Non-OP P/L 18,883 46,874 27,992 +148% Net Profit 138,403 194,135 55,732 +40% % 12% 13% 1% EPS 1.44 2.01 0.57 +40% 6
Slide 7: 2025 First Three Quarters Revenue
2025 First Three Quarters Revenue NT$ 4,140 millions (YoY+24%) record high for 5 consecutive years (NT$ millions) 2024 Q1~Q3 2025 Q1~Q3 YoY% Revenue 3,337.2 4,139.5 24% APAC 1,503.4 1,820.7 21% EMEA 1,079.2 1,441.5 34% AMERICA 754.6 877.2 16% 7
Slide 8: Revenue by Regions
Revenue by Regions 2024 Q1~Q3 2025 Q1~Q3 3,337M 4,140M AMERICA AMERICA 23% 21% APAC APAC 45% 44% EMEA EMEA 32% 35% 8
Slide 9: 2025 Q1~Q3 Performance
2025 Q1~Q3 Performance (NT$ thousands) 2024 Q1~Q3 2025 Q1~Q3 DIFF % 89% of Revenue 3,337,208 4,139,500 802,292 +24% 2024 Sales Operating P/L 441,401 559,474 118,073 +27% Non-OP P/L 11,484 24,557 13,072 +114% 95% of Net Profit 334,408 431,552 97,144 +29% 2024 Sales % 10% 10% - EPS 3.48 4.47 0.99 +29%
Slide 10: Operating Results by Quarter
Operating Results by Quarter Revenue Trend Chart Financial Ratios (NT$ millions) 1,492 2025 Q1~Q3 gross margin: 78%; operating expense ratio: 64% 1,351 7% 1,316 1,297 81% 93% 9% 79% 8% 8% 78% 78% 78% 78% 1,134 1,141 1,131 92% 91% 77% 77% 77% 76% 92% 76% 1,066 10% 10% 9% 933 934 8% 928 90% 90% 91% 92
Slide 11: Agenda
AGENDA I. 2025 first three quarters results II. Operations Status III. Q&A 11
Slide 12: United Orthopedics Corporation
United Orthopedics Corporation 12
Slide 13: Performance in the APAC Market
Performance in the APAC Market Q1~Q3 Sales (NT$ millions) +21% 1,821 Major Market: Taiwan+14% +13% 1,503 Japan+74% 1,329 2023 Q1~Q3 2024 Q1~Q3 2025 Q1~Q3 13
Slide 14: Performance in the EMEA Market
Performance in the EMEA Market Q1~Q3 Sales (NT$ millions) Major Market: 1,442 +34% France+23% +21% 1,079 889 2023 Q1~Q3 2024 Q1~Q3 2025 Q1~Q3 14
Slide 15: Performance in the AMERICA Market
Performance in the AMERICA Market Q1~Q3 Sales (NT$ millions) Major Market: +16% 877 U.S.+18% 755 +30% 578 2023 Q1~Q3 2024 Q1~Q3 2025 Q1~Q3 15
Slide 16: Revenue in October
Revenue in October NT$ 516 millions (YoY+12%) second highest in a single month (NT$ millions) October 2024 October 2025 YoY% Revenue 460.3 515.8 12% APAC 177.5 213.1 20% EMEA 151.8 180.8 19% AMERICA 131.0 121.9 -7% 16
Slide 17: Agenda
AGENDA I. 2025 first three quarters results II. Operations Status III. Q&A 17
Slide 18: Thank you for listening
Thank you for listening Each Step We Care